In a petition for a writ of mandamus filed on April 29, 2019
with the U.S. Court of Appeals for the D.C. Circuit, an
unidentified whistleblower who claims to have tipped the SEC to
alleged violations of the Foreign Corrupt Practices Act
("FCPA") by Teva Pharmaceuticals more than eight years
ago asked the court to compel the SEC to preliminarily determine
within 60 days if he is eligible for compensation under the
SEC's whistleblower program and issue a final order within six
months.
In re: John Doe, No. 19-1095 (D.C. Cir.).
According to the petition, the purported tipster submitted a
detailed, 42-page tip regarding Teva's alleged violations of
the FCPA in May 2011 that resulted in the prosecution by the SEC
and DOJ of successful enforcement actions regarding that same
conduct and the recovery of $519 million from Teva. The
petitioner maintains that he submitted a timely claim for an award
in April 2017 and the SEC's more than two-year delay in issuing
a